I
197.58
8.91 (4.72%)
| Penutupan Terdahulu | 188.67 |
| Buka | 186.54 |
| Jumlah Dagangan | 1,129,395 |
| Purata Dagangan (3B) | 908,949 |
| Modal Pasaran | 15,366,216,704 |
| Harga / Pendapatan (P/E TTM) | 26.63 |
| Harga / Pendapatan (P/E Ke hadapan) | 13.70 |
| Harga / Jualan (P/S) | 1.85 |
| Harga / Buku (P/B) | 1.53 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 22 Oct 2025 |
| Margin Keuntungan | 9.82% |
| Margin Operasi (TTM) | 12.83% |
| EPS Cair (TTM) | 9.71 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 24.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 37.12% |
| Nisbah Semasa (MRQ) | 1.29 |
| Aliran Tunai Operasi (OCF TTM) | 1.16 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 901.28 M |
| Pulangan Atas Aset (ROA TTM) | 4.35% |
| Pulangan Atas Ekuiti (ROE TTM) | 8.30% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menaik | Menaik |
| Diagnostics & Research (Global) | Menaik | Menaik | |
| Stok | ICON plc | Menaik | Menurun |
AISkor Stockmoo
-1.9
| Konsensus Penganalisis | -1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -1.5 |
| Purata | -1.88 |
|
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Value |
| % Dimiliki oleh Orang Dalam | 0.63% |
| % Dimiliki oleh Institusi | 92.70% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 222.00 (Truist Securities, 12.36%) | Pegang |
| Median | 191.50 (-3.08%) | |
| Rendah | 175.00 (BMO Capital, -11.43%) | Pegang |
| Purata | 195.00 (-1.31%) | |
| Jumlah | 4 Pegang | |
| Harga Purata @ Panggilan | 180.70 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| TD Cowen | 22 Jan 2026 | 183.00 (-7.38%) | Pegang | 186.74 |
| 24 Oct 2025 | 172.00 (-12.95%) | Pegang | 178.11 | |
| Truist Securities | 08 Jan 2026 | 222.00 (12.36%) | Pegang | 188.22 |
| Barclays | 15 Dec 2025 | 200.00 (1.22%) | Pegang | 184.37 |
| 24 Oct 2025 | 185.00 (-6.37%) | Pegang | 178.11 | |
| BMO Capital | 13 Nov 2025 | 175.00 (-11.43%) | Pegang | 163.45 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 09 Dec 2025 | Pengumuman | ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive |
| 02 Dec 2025 | Pengumuman | ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions |
| 12 Nov 2025 | Pengumuman | ICON plc to Present at the Jefferies London Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |